Arcellx (ACLX) Change in Acquisitions & Divestments (2022 - 2025)
Arcellx (ACLX) recorded quarterly Change in Acquisitions & Divestments of $108.2 million in Q4 2025, up 5.66% quarter-over-quarter from $102.4 million in Q3 2025, and down 19.07% on a YoY basis from $133.7 million in Q4 2024.
Arcellx (ACLX) Change in Acquisitions & Divestments (2022 - 2025) Analysis & Trends
Arcellx's Change in Acquisitions & Divestments history runs 4 years deep, the most recent figure standing at $108.2 million for Q4 2025.
- In Q4 2025, Change in Acquisitions & Divestments fell 19.07% year-over-year to $108.2 million; the TTM figure through Dec 2025 stood at $495.6 million (up 15.88% YoY), while the FY2025 annual figure was $495.6 million, up 15.88% from the prior year.
- Change in Acquisitions & Divestments was $108.2 million for Q4 2025 at Arcellx, up from $102.4 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $167.8 million in Q2 2025 to a low of $16.8 million in Q1 2022.
- Historically, Change in Acquisitions & Divestments has averaged $86.9 million across 4 years, with a median of $91.1 million in 2023.
- The sharpest annual moves came in 2023 and 2025: Change in Acquisitions & Divestments surged 471.81% in 2023, then slipped 19.07% in 2025.
- A 4-year view of Change in Acquisitions & Divestments shows it stood at $60.7 million in 2022, then increased by 13.26% to $68.7 million in 2023, then jumped by 94.63% to $133.7 million in 2024, then slipped by 19.07% to $108.2 million in 2025.
- The last three Change in Acquisitions & Divestments figures came in at $108.2 million (Q4 2025), $102.4 million (Q3 2025), and $167.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 108.20 Mn |
| Dec 31, 2025 | 108.20 Mn |
| Sep 30, 2025 | 102.40 Mn |
| Sep 30, 2025 | 102.40 Mn |
| Jun 30, 2025 | 167.80 Mn |
| Jun 30, 2025 | 167.80 Mn |
| Mar 31, 2025 | 117.20 Mn |
| Mar 31, 2025 | 117.20 Mn |
| Dec 31, 2024 | 133.70 Mn |
| Dec 31, 2024 | 133.70 Mn |
| Sep 30, 2024 | 98.00 Mn |
| Sep 30, 2024 | 98.00 Mn |
| Jun 30, 2024 | 78.00 Mn |
| Jun 30, 2024 | 78.00 Mn |
| Mar 31, 2024 | 118.00 Mn |
| Mar 31, 2024 | 118.00 Mn |
| Dec 31, 2023 | 68.70 Mn |
| Dec 31, 2023 | 68.70 Mn |
| Sep 30, 2023 | 85.80 Mn |
| Sep 30, 2023 | 85.80 Mn |